Premium
Prognostic importance of cognitive impairment in chronic heart failure patients: Does specialist management make a difference?
Author(s) -
McLennan Skye N.,
Pearson Sue A.,
Cameron Janette,
Stewart Simon
Publication year - 2006
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2005.11.013
Subject(s) - medicine , heart failure , cognitive impairment , cardiology , cognition , intensive care medicine , psychiatry
Background: Cognitive impairment is common among chronic heart failure (CHF) patients. Aims: To determine the prognostic significance of cognitive impairment in patients participating in a randomized study of a CHF management program (CHF‐MP). Methods CHF patients were randomized to a CHF‐MP ( n =100) or usual care ( n =100). Baseline cognition was assessed using the Mini Mental Status Examination (MMSE). Five‐year all‐cause mortality, and combined death‐or‐readmission, were compared on the basis of the presence (MMSE 19–26) or absence (MMSE >26) of cognitive impairment. Results: 27 patients (13.5%) had cognitive impairment and, on an adjusted basis, were more likely to die (96.3% versus 68.2%. RR 2.19, 95% CI 1.41 to 3.39: P <0.001) and/or experience an unplanned hospitalization (100% versus 94%. RR 1.44, 95% CI 1.06 to 1.95: P =0.019). Cognitively impaired patients had a similar (non‐significant) adjusted risk of death‐or‐readmission in both the CHF‐MP (RR 1.40, 95% CI 0.63 to 3.11: P =0.403) and in usual care (RR 1.38, 95% CI 0.75 to 2.53: P =0.305). In the usual care cohort, cognitive impairment was associated with a greater (non‐significant), adjusted risk of death (RR 1.61, 95% CI 1.10 to 4.92: P =0.122). In the CHF‐MP, adjusted risk of death was significantly higher for cognitively impaired patients (RR 2.33, 95% CI 1.10 to 4.92: P =0.027). Conclusion These data suggest that “mild” cognitive impairment is of prognostic importance in CHF: even when a CHF‐MP has been applied.